Cargando…

A critical evaluation of glucocorticoids in the management of severe COVID-19

The viral infection by SARS-CoV-2 has irrevocably altered the life of the majority of human beings, challenging national health systems worldwide, and pushing researchers to rapidly find adequate preventive and treatment strategies. No therapies have been shown effective with the exception of dexame...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solinas, Cinzia, Perra, Laura, Aiello, Marco, Migliori, Edoardo, Petrosillo, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313507/ https://www.ncbi.nlm.nih.gov/pubmed/32616381 http://dx.doi.org/10.1016/j.cytogfr.2020.06.012

Ejemplares similares

Programmed Cell Death-Ligand 2: A Neglected But Important Target in the Immune Response to Cancer?
por: Solinas, Cinzia, et al.
Publicado: (2020)

LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
por: Solinas, Cinzia, et al.
Publicado: (2019)

Glucocorticoid benefits the ventilatory function of severe/critical COVID-19 patients
por: Xiong, Xiaoming, et al.
Publicado: (2021)

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
por: Jiménez-Brítez, Gustavo, et al.
Publicado: (2020)

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
por: Jiménez-Brítez, Gustavo, et al.
Publicado: (2020)

The Role of Glucocorticoids in the Management of COVID-19
por: Alexaki, Vasileia Ismini, et al.
Publicado: (2021)

Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
por: Xiang, Zhen, et al.
Publicado: (2020)

Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy
por: Chrousos, George P., et al.
Publicado: (2020)

Non-pharmaceutical interventions during the COVID-19 pandemic: A review
por: Perra, Nicola
Publicado: (2021)

Management of Patients With Glucocorticoid-Related Diseases and COVID-19
por: Chifu, Irina, et al.
Publicado: (2021)

Real-world evidence of the use of glucocorticoids for severe COVID-19
por: Albarrán-Sánchez, Alejandra, et al.
Publicado: (2022)

COVID-19 R0: Magic number or conundrum?
por: Viceconte, Giulio, et al.
Publicado: (2020)

Perioperative Evaluation and Management of Patients on Glucocorticoids
por: Chen Cardenas, Stanley M, et al.
Publicado: (2022)

363 Management of severe and critical COVID-19 in pregnancy
por: Trahan, Marie Julie, et al.
Publicado: (2021)

Management of Severe and Critical COVID-19 Infection with Immunotherapies
por: Athale, Janhavi, et al.
Publicado: (2022)

Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids
por: Hsieh, Tien-Chan, et al.
Publicado: (2021)

Renaissance of glucocorticoids in critical care in the era of COVID-19: ten urging questions
por: Winkler, Martin S., et al.
Publicado: (2022)

Clinical observation of glucocorticoid therapy for critically ill patients with COVID-19 pneumonia
por: Zhu, Yingjie, et al.
Publicado: (2023)

Glucocorticoids and COVID-19
por: Bruscoli, Stefano, et al.
Publicado: (2022)

Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
por: Salton, Francesco, et al.
Publicado: (2023)

Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy
por: Cho, Eun-Hee
Publicado: (2023)

Tailoring glucocorticoids in patients with severe COVID-19: a narrative review
por: Luo, Ming-Hao, et al.
Publicado: (2021)

Critical Care Management of Severe COVID-19 in Pregnant Patients
por: Ghafoor, Hashsaam, et al.
Publicado: (2022)

Pituitary–Adrenal Responses and Glucocorticoid Receptor Expression in Critically Ill Patients with COVID-19
por: Vassiliadi, Dimitra A., et al.
Publicado: (2021)

Effect of combining anticoagulant and glucocorticoid therapy on mortality in patients with severe COVID-19
por: Shi, Can, et al.
Publicado: (2022)

Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
por: Badagliacca, Roberto, et al.
Publicado: (2020)

Glucocorticoids and the Brain after Critical Illness
por: Hill, Alice R, et al.
Publicado: (2021)

Investigating the response to COVID-19 and understanding severe TB cases: The 2022 Pulmonology TB series
por: Migliori, G.B., et al.
Publicado: (2022)

Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Moderate to Severe COVID-19
por: Prasenohadi, Prasenohadi, et al.
Publicado: (2022)

Critical illness neuropathy in severe COVID-19
por: Bocci, Tommaso, et al.
Publicado: (2021)

The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout
por: Gozzi, Nicolò, et al.
Publicado: (2021)

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression
por: Pellegrino, Benedetta, et al.
Publicado: (2021)

Glucocorticoid excess and COVID-19 disease
por: Guarnotta, Valentina, et al.
Publicado: (2020)

The critical role of T cells in glucocorticoid-induced osteoporosis
por: Song, Lin, et al.
Publicado: (2020)

Association of COVID-19 case fatality rate with disease burden: an ecological analysis in Italy during the first wave
por: Timelli, Laura, et al.
Publicado: (2021)

A real‐world study of glucocorticoid treatment in COVID‐19 patients with different disease severities
por: Jiao, Xiaofei, et al.
Publicado: (2020)

The association between pre-exposure to glucocorticoids and other immunosuppressant drugs with severe COVID-19 outcomes
por: Brodin, Rakel, et al.
Publicado: (2022)

The role of the glucocorticoid receptor and its impact on steroid response in moderate-severe COVID-19 patients
por: Aliska, Gestina, et al.
Publicado: (2023)

The adoption of non-pharmaceutical interventions and the role of digital infrastructure during the COVID-19 pandemic in Colombia, Ecuador, and El Salvador
por: Gozzi, Nicolò, et al.
Publicado: (2023)

Glucocorticoid-Glucocorticoid Receptor Response to Severe Acute Respiratory Syndrome Coronavirus 2*
por: Annane, Djillali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ovkc88ajb951ndvla10fuurtc